HKD 3.45
(2.37%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 11.96 Billion HKD | 9.12% |
2022 | 10.96 Billion HKD | 2.41% |
2021 | 10.7 Billion HKD | 15.72% |
2020 | 9.25 Billion HKD | 19.8% |
2019 | 7.72 Billion HKD | 12.26% |
2018 | 6.88 Billion HKD | 16.54% |
2017 | 5.9 Billion HKD | 24.45% |
2016 | 4.74 Billion HKD | -5.27% |
2015 | 5 Billion HKD | 4.39% |
2014 | 4.79 Billion HKD | -5.63% |
2013 | 5.08 Billion HKD | 27.37% |
2012 | 3.99 Billion HKD | 15.88% |
2011 | 3.44 Billion HKD | 2.13% |
2010 | 3.37 Billion HKD | 34.89% |
2009 | 2.5 Billion HKD | -0.45% |
2008 | 2.51 Billion HKD | 21.21% |
2007 | 2.07 Billion HKD | 127.07% |
2006 | 912.44 Million HKD | 1.3% |
2005 | 900.74 Million HKD | 22.0% |
2004 | 738.32 Million HKD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 12.54 Billion HKD | 0.0% |
2023 FY | 11.96 Billion HKD | 9.12% |
2023 Q4 | 11.96 Billion HKD | 0.0% |
2023 Q2 | 11.33 Billion HKD | 0.0% |
2022 Q4 | 10.96 Billion HKD | 0.0% |
2022 FY | 10.96 Billion HKD | 2.41% |
2022 Q2 | 10.98 Billion HKD | 0.0% |
2021 FY | 10.7 Billion HKD | 15.72% |
2021 Q4 | 10.7 Billion HKD | 0.0% |
2021 Q2 | 9.56 Billion HKD | 0.0% |
2020 Q2 | 7.97 Billion HKD | 0.0% |
2020 FY | 9.25 Billion HKD | 19.8% |
2020 Q4 | 9.25 Billion HKD | 0.0% |
2019 Q2 | 7.34 Billion HKD | 0.0% |
2019 Q4 | 7.72 Billion HKD | 0.0% |
2019 FY | 7.72 Billion HKD | 12.26% |
2018 Q4 | 6.88 Billion HKD | 0.0% |
2018 FY | 6.88 Billion HKD | 16.54% |
2018 Q2 | 6.04 Billion HKD | 0.0% |
2017 Q4 | 5.9 Billion HKD | 0.0% |
2017 FY | 5.9 Billion HKD | 24.45% |
2017 Q2 | 5.09 Billion HKD | 0.0% |
2016 Q4 | 4.74 Billion HKD | 0.0% |
2016 FY | 4.74 Billion HKD | -5.27% |
2016 Q2 | 4.97 Billion HKD | 0.0% |
2015 FY | 5 Billion HKD | 4.39% |
2015 Q4 | 5 Billion HKD | 0.0% |
2015 Q2 | 4.92 Billion HKD | 0.0% |
2014 Q2 | 5.53 Billion HKD | 0.0% |
2014 Q4 | 4.79 Billion HKD | 0.0% |
2014 FY | 4.79 Billion HKD | -5.63% |
2013 Q4 | 5.08 Billion HKD | 0.0% |
2013 Q2 | 4.49 Billion HKD | 0.0% |
2013 FY | 5.08 Billion HKD | 27.37% |
2012 FY | 3.99 Billion HKD | 15.88% |
2012 Q2 | 3.67 Billion HKD | 0.0% |
2012 Q4 | 3.99 Billion HKD | 0.0% |
2011 Q4 | 3.44 Billion HKD | 0.0% |
2011 FY | 3.44 Billion HKD | 2.13% |
2011 Q2 | 3.39 Billion HKD | 0.0% |
2010 Q4 | 3.37 Billion HKD | 0.0% |
2010 Q2 | 3.04 Billion HKD | 0.0% |
2010 FY | 3.37 Billion HKD | 34.89% |
2009 Q4 | 2.5 Billion HKD | 0.0% |
2009 FY | 2.5 Billion HKD | -0.45% |
2008 FY | 2.51 Billion HKD | 21.21% |
2007 FY | 2.07 Billion HKD | 127.07% |
2006 FY | 912.44 Million HKD | 1.3% |
2005 FY | 900.74 Million HKD | 22.0% |
2004 FY | 738.32 Million HKD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Pak Fah Yeow International Limited | 907.46 Million HKD | -1218.655% |
Grand Pharmaceutical Group Limited | 22.51 Billion HKD | 46.852% |
Extrawell Pharmaceutical Holdings Limited | 1.28 Billion HKD | -829.649% |
Wai Yuen Tong Medicine Holdings Limited | 2.09 Billion HKD | -471.156% |
Qianhai Health Holdings Limited | 478.11 Million HKD | -2402.805% |
Lee's Pharmaceutical Holdings Limited | 2.89 Billion HKD | -313.965% |
Essex Bio-Technology Limited | 2.82 Billion HKD | -323.204% |
Tongfang Kontafarma Holdings Limited | 1.72 Billion HKD | -592.763% |
PuraPharm Corporation Limited | 843.96 Million HKD | -1317.874% |
JBM (Healthcare) Limited | 1.38 Billion HKD | -761.695% |
Jacobson Pharma Corporation Limited | 3.48 Billion HKD | -243.184% |
China Resources Pharmaceutical Group Limited | 271.69 Billion HKD | 95.596% |